Each factor with its sector median and, where it's reported per quarter, its last 12 quarters.
GMEDSector12 quartersMarket cap$10.97B$9.67BEnterprise value—$10.41BAvg daily $ volume$134.03M$132.68MDaily turnover1.2%1.3%
GMEDSector12 quartersRevenue CAGR 3y42.1%9.5%Revenue CAGR 5y27.7%8.9%Revenue growth YoY5.9%8.7%Revenue acceleration−21.1 pp+0.0 ppFCF growth YoY43.3%5.9%FCF conversion141.1%130.8%Forward growth (HoM est.)24.0%9.8% GMEDSector12 quartersP/E (trailing)20.5×27.6×P/E (forward, HoM est.)16.5×25.2×P/E vs. sector0.8×1.0×PEG (HoM est.)0.693.12EV/EBITDA—17.5×EV/Sales—3.3×FCF yield—3.6%Dividend yield0.0%0.0%Shareholder yield2.0%1.2%
GMEDSector12 quartersQuality checks passed23ROIC—9.2%Gross profitability39.3%32.6%Gross margin68.5%60.1%Gross margin Δ 3y−5.6 pp−0.1 ppOperating margin20.3%10.6%Operating margin Δ 3y−1.2 pp+0.9 ppDebt/equity—0.7×Net debt/EBITDA—2.0×Interest coverage—4.9×Share count Δ 3y33.7%-0.3%Stock compensation / revenue1.6%1.8%Accruals ratio-7.2%-4.3% GMEDSector12 quartersDays to next report1413
GMEDSector12 quartersInsider buys (90d)00Insiders buying (90d)00Insider net value (90d)-$4.41M$0Institutional ownership88.6%99.6%Institutional Δ QoQ+7.1 pp+1.1 ppConviction funds net buying—−0.0 ppActive managers net buying+0.4 pp+0.1 ppActive funds net buying+0.1 pp+0.0 ppDays to cover5.144.29Short % of shares out6.3%6.0%Short interest Δ+1.2 pp+0.1 pp